CRUK’s Early Diagnosis Research Conference

More than 354,000 people are diagnosed with cancer in the UK each year, up 12% since the mid 90’s. But thanks to research, survival is also increasing for many cancers and people are living longer after a cancer diagnosis.

CRUK state that early diagnosis is key to achieving 3 in 4 people surviving their cancer by 2034. By 2019 Cancer Research UK will be investing £20 million into early diagnosis.

When cancer is diagnosed at an early stage, treatment options and chances of a full recovery are greater.

The aim of NAEDI is to promote earlier diagnosis of cancer, increasing access to optimal treatment and thereby improving survival rates and reducing cancer mortality through a variety of means.

At Pancreatic Cancer Action, we believe the early diagnosis is key to saving lives and improving survival rates.  By prompting, coordinating and supporting early diagnosis activity, we aim to make a difference to the lives of thousands of people affected by pancreatic cancer each year.

Over 30% of pancreatic cancer patients diagnosed with the earliest stage of disease survive at least five years compared with less than 5% of those diagnosed with the most advanced stage disease.

Read a bit more about the latest conference: Fourth Biennial Early Diagnosis Research Conference 23-24 February 2017

To find out more about NAEDI, visit: